Results 1 to 10 of about 3,637,017 (328)
The Safety of Antirheumatic Drugs [PDF]
Dtsch Arztebl Int, 2022 BACKGROUND Drug therapy for rheumatic diseases has changed fundamentally in recent decades with the introduction of many new agents. As these drugs may have to be taken for many years, and many of them are of similar efficacy, their safety profiles play an important role in therapeutic decisionmaking.
Mucke J, Simon H, Rüdiger Burmester G.
europepmc +3 more sources
The in vitro effect of antirheumatic drugs on platelet function
Platelets, 2020 Several antirheumatic drugs lower the cardiovascular risk among rheumatoid arthritis patients. It is, however, unknown whether inhibition of platelet function contributes to this risk reduction.
Camilla Brødsgaard Nielsen +4 more
doaj +2 more sources
Adherence to the antirheumatic drugs: a systematic review and meta-analysis [PDF]
Frontiers in MedicineIntroductionThis systematic review and meta-analysis aimed to analyze the adherence rate for conventional and biological disease-modifying antirheumatic drugs (DMARDs) utilizing different assessment measures.MethodA systematic literature search was ...
Nilay Aksoy +4 more
doaj +2 more sources
Antirheumatic Drugs and the Risk of Tuberculosis [PDF]
Clinical Infectious Diseases, 2006 We aimed to quantify the rate of Mycobacterium tuberculosis disease (TB) among a cohort of patients with rheumatoid arthritis (RA) and to assess whether the independent use of disease-modifying antirheumatic drugs (DMARDs) is associated with the risk of developing TB.The study was performed using the PharMetrics Patient-Centric database (PharMetrics ...
Samy Suissa +3 more
openaire +4 more sources
Combination of Second-line Antirheumatic Drugs [PDF]
Annals of Medicine, 1997 Single drug therapy is often not satisfactory in the treatment of chronic arthritis. The combination of second-line antirheumatic drugs is therefore increasingly employed. Various strategies of combining drugs can be used, starting with combinations or adding agents in case of insufficient effect of single therapy.
Haagsma, C.J., Riel, P.L.C.M. van
openaire +6 more sources
Risk of Herpes Zoster in Individuals on Biologics, Disease-Modifying Antirheumatic Drugs, and/or Corticosteroids for Autoimmune Diseases: A Systematic Review and Meta-Analysis [PDF]
Open Forum Infectious Diseases, 2016 Background. Studies examining the risk of herpes zoster (HZ) associated with immunosuppressants, such as biologics, nonbiological disease-modifying antirheumatic drugs (nbDMARDs), or corticosteroids, have generated conflicting results. Methods.
Fawziah Marra +3 more
openalex +2 more sources
Health Technology Assessment, 2016 OBJECTIVES Rheumatoid arthritis (RA) is a chronic inflammatory disease associated with increasing disability, reduced quality of life and substantial costs (as a result of both intervention acquisition and hospitalisation).
Matt Stevenson +11 more
openalex +3 more sources
Aphthous colitis induced by non-steroidal antirheumatic drugs
Swiss Medical Weekly, 2003 I Zuber-Jerger
doaj +2 more sources
Disease-modifying antirheumatic drugs [PDF]
Nursing, 2010 Jennifer M. Belavic
openaire +4 more sources
JAMA Network Open, 2023 This cohort study evaluates the incidence of interstitial lung disease in patients with rheumatoid arthritis who have been treated with biologic and targeted synthetic disease-modifying antirheumatic drugs.
Matthew C. Baker +5 more
semanticscholar +1 more source